Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Axcan, Cellerix in Cx401 deal

Cellerix (Madrid, Spain) granted gastrointestinal company Axcan (TSX:AXP; AXCA) exclusive North

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE